Cargando…
Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed f...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707627/ https://www.ncbi.nlm.nih.gov/pubmed/33281265 http://dx.doi.org/10.30476/ijms.2019.81934 |
_version_ | 1783617391215771648 |
---|---|
author | Dalimi-Asl, Somaye Babaahmadi-Rezaei, Hossein Mohammadzadeh, Ghorban |
author_facet | Dalimi-Asl, Somaye Babaahmadi-Rezaei, Hossein Mohammadzadeh, Ghorban |
author_sort | Dalimi-Asl, Somaye |
collection | PubMed |
description | BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed from October 2017 to April 2018 at the Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The cytotoxic effect of silibinin and curcumin, individually and combined, and their corresponding half-maximal inhibitory concentration (IC(50)) values were determined using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. The cells were treated with different concentrations of silibinin (50-400 μM), curcumin (10-35 μM), and their combinations for 24 and 48 hours. The expression of Ob-R was measured using the Western blot analysis by treating the cells with different concentrations of curcumin (10-25 μM), silibinin (50-250 μM), and their respective combinations. The difference in mean cell viability between the groups was calculated using one-way ANOVA followed by Tukey’s post hoc test. RESULTS: Silibinin and curcumin exerted time- and dose-dependent cytotoxic effect on MCF-7 cells. After treatment with silibinin, the IC(50) values were about 250 and 50 μM at 24 and 48 hours, respectively. In terms of treatment with curcumin, the IC(50) values were about 25 and 15 μM at 24 and 48 hours, respectively. Following treatment with silibinin, the Western blot analysis showed that Ob-R expression significantly decreased at 150 μM (P=0.031) and 200 μM (P=0.023) concentrations. Curcumin did not significantly decrease the Ob-R expression, however, the expression significantly decreased (P=0.004) when it was combined with silibinin. CONCLUSION: The combination of silibinin and curcumin significantly reduced Ob-R expression in MCF-7 cells compared with their individual effects. |
format | Online Article Text |
id | pubmed-7707627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Shiraz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-77076272020-12-05 Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line Dalimi-Asl, Somaye Babaahmadi-Rezaei, Hossein Mohammadzadeh, Ghorban Iran J Med Sci Original Article BACKGROUND: Leptin and leptin receptor (Ob-R) are associated with worse prognosis, distant metastasis, and poor survival of breast cancer. We investigated the cytotoxic effect of silibinin and curcumin, individually and combined, on Ob-R expression in MCF-7 cells. METHODS: This study was performed from October 2017 to April 2018 at the Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The cytotoxic effect of silibinin and curcumin, individually and combined, and their corresponding half-maximal inhibitory concentration (IC(50)) values were determined using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. The cells were treated with different concentrations of silibinin (50-400 μM), curcumin (10-35 μM), and their combinations for 24 and 48 hours. The expression of Ob-R was measured using the Western blot analysis by treating the cells with different concentrations of curcumin (10-25 μM), silibinin (50-250 μM), and their respective combinations. The difference in mean cell viability between the groups was calculated using one-way ANOVA followed by Tukey’s post hoc test. RESULTS: Silibinin and curcumin exerted time- and dose-dependent cytotoxic effect on MCF-7 cells. After treatment with silibinin, the IC(50) values were about 250 and 50 μM at 24 and 48 hours, respectively. In terms of treatment with curcumin, the IC(50) values were about 25 and 15 μM at 24 and 48 hours, respectively. Following treatment with silibinin, the Western blot analysis showed that Ob-R expression significantly decreased at 150 μM (P=0.031) and 200 μM (P=0.023) concentrations. Curcumin did not significantly decrease the Ob-R expression, however, the expression significantly decreased (P=0.004) when it was combined with silibinin. CONCLUSION: The combination of silibinin and curcumin significantly reduced Ob-R expression in MCF-7 cells compared with their individual effects. Shiraz University of Medical Sciences 2020-11 /pmc/articles/PMC7707627/ /pubmed/33281265 http://dx.doi.org/10.30476/ijms.2019.81934 Text en Copyright: © Iranian Journal of Medical Sciences http://creativecommons.org/licenses/by-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Dalimi-Asl, Somaye Babaahmadi-Rezaei, Hossein Mohammadzadeh, Ghorban Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title | Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title_full | Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title_fullStr | Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title_full_unstemmed | Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title_short | Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line |
title_sort | combination of silibinin and curcumin reduced leptin receptor expression in mcf-7 human breast cancer cell line |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707627/ https://www.ncbi.nlm.nih.gov/pubmed/33281265 http://dx.doi.org/10.30476/ijms.2019.81934 |
work_keys_str_mv | AT dalimiaslsomaye combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline AT babaahmadirezaeihossein combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline AT mohammadzadehghorban combinationofsilibininandcurcuminreducedleptinreceptorexpressioninmcf7humanbreastcancercellline |